drugset / Trial / NCT01312935
Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study investigates the safety and efficacy of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Timeline
- Start
- 2011-04
- Primary completion
- 2012-06
- Completion
- 2012-08
Outcome
Outcome not reported
Stopped (Enrollment): “PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions in blood pressure.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DELPARANTAG | Small molecule | — | — |